DECEMBER - 19 - 2022$15www.pharmatechoutlook.comISSN 2644-2787PHARMA COMPLIANCEE DI T IO NSTREAMLINING AUTHORING AND GLOBAL LABELLINGGLEMSERKevin Morgan, CEO
Page 2 >